1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for the United
States Induced Pluripotent Stem Cells Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in the United
States Induced Pluripotent Stem Cells Market
4.
United States Induced Pluripotent
Stem Cells Market by Derived Cell Type
4.1.
Fibroblasts
4.2.
Amniotic Cells
4.3.
Hepatocytes
4.4.
Keratinocytes
4.5.
Others
5.
United States Induced Pluripotent
Stem Cells Market by Application
5.1.
Drug Development
5.2.
Regenerative Medicine
5.3.
Toxicity Testing
5.4.
Academic Research
6.
United States Induced Pluripotent
Stem Cells Market by End User
6.1.
Research Organizations
6.2. Hospitals
6.3.
Bio-pharma
Industries
7.
Company Profiles
7.1.
Company 1
7.2.
Company 2
7.3.
Company 3
7.4.
Company 4
7.5.
Company 5
1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for the United
States Induced Pluripotent Stem Cells Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in the United
States Induced Pluripotent Stem Cells Market
4.
United States Induced Pluripotent
Stem Cells Market by Derived Cell Type
4.1.
Fibroblasts
4.2.
Amniotic Cells
4.3.
Hepatocytes
4.4.
Keratinocytes
4.5.
Others
5.
United States Induced Pluripotent
Stem Cells Market by Application
5.1.
Drug Development
5.2.
Regenerative Medicine
5.3.
Toxicity Testing
5.4.
Academic Research
6.
United States Induced Pluripotent
Stem Cells Market by End User
6.1.
Research Organizations
6.2. Hospitals
6.3.
Bio-pharma
Industries
7.
Company Profiles
7.1.
Company 1
7.2.
Company 2
7.3.
Company 3
7.4.
Company 4
7.5.
Company 5